PURE Bioscience (NASDAQ:PURE) announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE’s revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.
PURE’s patented antimicrobial SDC (silver dihydrogen citrate) is the first new generation disinfectant to be registered with the U.S. Environmental Protection Agency in more than 30 years.
Unlike traditional alcohol- or bleach-based surface disinfectants, SDC-based disinfectants continue killing bacteria for up to 24 hours. Bacterial kill times for SDC are as quick as 30 seconds, compared with up to ten minutes for other products.
PURE’s CEO, Michael L. Krall, said today’s announcement represents a new, more aggressive approach to selling by PURE Bioscience. “Public concern is rising sharply over the serious health dangers of illnesses such as Swine Flu. We have extraordinary new technology and products that can protect lives. It is time to take a more direct role in getting our products into businesses, homes, schools, hospitals and anywhere they can help fight against illness caused by viruses and bacteria.”
“We are truly excited to be working with PURE to bring these extraordinary products to the places where they are so desperately needed to protect against illness,” said John Rochon, Richmont’s chairman. “This is more than just marketing. It is about saving lives by introducing a whole new category of long-lasting, broad spectrum germicides.”